Advertisement

Ads Placeholder
Loading...

BridgeBio Pharma, Inc.

BBIO•NASDAQ
Healthcare
Biotechnology
$73.15
$-1.30(-1.75%)
U.S. Market opens in 32h 11m

BridgeBio Pharma, Inc. (BBIO) Stock Overview

Explore BridgeBio Pharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap14.2B
P/E Ratio-19.78
EPS (TTM)$-3.78
ROE0.39%
Fundamental Analysis

AI Price Forecasts

1 Month$64.32
3 Months$80.14
1 Year Target$73.29

BBIO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BridgeBio Pharma, Inc. (BBIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $73.29.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -19.78 and a market capitalization of 14.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.75%
5-Day Change
1.13%
1-Month Change
13.36%
3-Month Change
-6.51%
6-Month Change
38.38%
Year-to-Date (YTD) Change
-6.51%
1-Year Change
114.71%
3-Year Change
341.46%
5-Year Change
24.004%
All-Time (Max) Change
165.52%

Contact Information

https://www.bridgebio.com
650 391 9740
421 Kipling Street, Palo Alto, CA, 94301

Company Facts

7,250 Employees
IPO DateJun 27, 2019
CountryUS
Actively Trading

Frequently Asked Questions